Navigation Links
Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
Date:10/8/2008

PT. RICHMOND, Calif., Oct. 8 /PRNewswire/ -- Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that Thomas P. Soloway, Senior Vice President and Chief Financial Officer, is scheduled to present at the Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City on Monday, October 13, 2008 at 9:30 AM Eastern Time.

An audio webcast of the presentation will be available at http://www.wsw.com/webcast/nblr2/transcept/ and on the Transcept website at http://www.transcept.com. The replay of the presentation will be available for 30 days.

About Transcept Pharmaceuticals

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the fields of psychiatry and sleep medicine. The lead Transcept product candidate, Intermezzo(R), is a sublingual low dose formulation of zolpidem that has been developed for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep. Phase 3 clinical trials have been completed for Intermezzo(R) and, on September 30, 2008, Transcept submitted a New Drug Application to the U.S. Food and Drug Administration. For further information, please visit the company's website at: http://www.transcept.com.

Safe Harbor

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). Transcept disclaims any intent or obligation to update these forward-looking statements, and claim the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to, the
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Transcept Pharmaceuticals Appoints Key Senior Executives
2. Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
3. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
4. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
5. VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
7. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
8. VioQuest Pharmaceuticals, Inc Valuation Upgrade Review Issued By Scimitar Equity, LLC
9. Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management
10. Alseres Pharmaceuticals, Inc. Raises $5 Million
11. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/ -- Biotech firm Replikins Ltd., which has...18 pandemic through the prediction, outbreak, and ...d its latest biochemical analysis of the virus. Th...Swine Flu") virus has dropped from its peak of 3.7... the spring of 2009 to resting non-epidemic levels...
(Date:11/25/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Brazil Bioethanol Market Analysis and....com/p0165503/Brazil-Bioethanol-Market-Analysis-an...Market Analysis and Forecasts to 2013 ,, Summa...d forecasts of the global bioethanol market and th...
(Date:11/24/2009)... investment bank KTA Capital,s client Neuren Pharm...convertible note private placement with a U.S. ins...anged by KTA Capital as Neuren,s exclusive placeme...ew York (PRWEB) November 23, 2009 -- The independe...t;KTA Capital") has announced that its client...
(Date:11/24/2009)... employment grew by 29,000 jobs in October, and t...rowth during the U.S. recession. However, clinics ...lth systems are coming closer to having to actuall...ators. , (Vocus) November...ing in October despite the shedding of jobs in mos...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...1 DOR BioPharma, Inc. (OTC Bulletin Board: DORB) ...al company, today announced its financial results ...ximately $2.3 million compared to $1.3 million in ...with DOR,s September 2006 NIH grant and the result...t milestones with our subcontractors. , , DOR,s ...
... RSCI,s Chairman expressed his concern that since ...y for medical treatments, America needs to put mor...eatments to alleviate the suffering of millions di... Bangkok, Thailand (PRWEB) Ma...,s first stem cell treatment company and chairman ...
...rcell,s first marketed product, a new vaccine agai...ry personnel , , - Commercial product launch in ... Intercell AG (VSE: ICLL) today announced that th... IXIARO(R), a new vaccine for the prevention of Ja...se of Intercell,s vaccine - the only such product ...
Other Biology Technology:DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 2DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 3DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 4DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 5Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research 2Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research 3Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 2Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 3Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 4
(Date:11/24/2009)... and the American College of Medical Toxicology (A...e publication of the Journal of Medical Toxicolog...ing in March 2010. It was previously published by...ournal of Medical Toxicology , an international, p...e science and practice of medical toxicology. The...
(Date:11/24/2009)...lease is available in Spanish . , The prese...vels of inflammatory substances in the blood, hind...own by a research project of the University of Nav...ntist at the School of Pharmacy. , The project, ... relation to the control of body weight and inflam...
(Date:11/23/2009)...study by the Wildlife Conservation Society says th...p in the Republic of Congopart of the "mother lode...arare becoming increasingly threatened by growing ...mends protection of the swamp forests adjacent to ...fter recent surveys confirmed that high densities ...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Repligen to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference Wednesday September 9th 2 3A25 p m EDT 13791 1Repligen to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference Wednesday September 9th 2 3A25 p m EDT 13791 2Repligen to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference Wednesday September 9th 2 3A25 p m EDT 13791 3Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 1Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 2Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 3Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 1Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 2Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 3Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 4
...ovember 2008 - Today, the European Molecular Biolo...12 of Europe,s most talented young researchers as ...Programme. , Now in its ninth year, the programme...ing European young researchers at a critical stage...receive a range of benefits designed to smooth the...
...ed study published October 29 in the online, open-...chlaug and Ellen Winner has found that children wh...ars outperform children with no instrumental train...d finger dexterity (skills honed by the study of a...verbal ability and visual pattern completion (skil...
... researcher Robin Gremaud has shown that an alloy ...cellent at absorbing hydrogen. This light alloy br...gen as a source of fuel for powering vehicles. A h...ive weight that is sixty percent less than a batte...eveloped a method which enabled simultaneous testi...
Other Biology News:12 outstanding young scientists named as EMBO Young Investigators 2Research shows that time invested in practicing pays off for young musicians 2Hydrogen tank lighter than battery 2
iEMS Incubator/Shaker 3 module from Thermo Scientific
Nepehloskan Ascent w/ 1st dispenser from Thermo Scientific
...lus USBio Analyzed PRODUCT SPECIFICATIONS Form: Wh...ntity (A,B): Passes tests pH (10 units/ml): 4.5 to...pper (Cu): less than or equal to 0.1% Bleomycin Co...reater than or equal to 90% B 4 : less than or equ...
...tical performance for all vacuum requirements. A 3...rmance to suit all applications. The large, sidevi...roper oil levels at a glance. The VLP series of pu...edVac concentrating and freeze drying systems for ...
Biology Products: